Group One Trading’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Group One Trading’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-73	Closed	-$19	–	8492
2023 Q1	$19	Hold	73	–	–	﹤0.01%	7080
2022 Q4	$86	Buy	+73	New	+$154	﹤0.01%	7079

Group One Trading's PEAR Position: Q2 2023 in Review

Group One Trading sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 73 shares — an estimated $19 sold.

Group One Trading first reported a position in PEAR in Q4 2022 and held it in 2 quarters. The position peaked at $86 in Q4 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Group One Trading reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 73 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $19.
Group One Trading first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Group One Trading's Pear Therapeutics, Inc. Class A Common Stock position peaked at $86 in Q4 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.